Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Maplebear | CART | Nov 26, 2024 | 43.54 | -0.16 |
Marathon Digital | MARA | Nov 26, 2024 | 24.97 | -5.49 |
Marathon Oil | MRO | Nov 26, 2024 | 28.55 | 0.00 |
Marathon Petroleum | MPC | Nov 26, 2024 | 157.14 | +0.41 |
Maravai LifeSciences A | MRVI | Nov 26, 2024 | 5.62 | +6.24 |
Marblegate Acquisition A | GATE | Nov 26, 2024 | 11.13 | 0.00 |
Marchex B | MCHX | Nov 26, 2024 | 1.73 | -0.57 |
Marcus | MCS | Nov 26, 2024 | 21.92 | -0.81 |
Marcus & Millichap | MMI | Nov 26, 2024 | 41.90 | -0.76 |
Marex Group | MRX | Nov 26, 2024 | 29.21 | +0.90 |
Marin Software | MRIN | Nov 26, 2024 | 2.30 | +8.70 |
Marine Petroleum Trust U | MARPS | Nov 26, 2024 | 3.98 | -1.97 |
Marine Products | MPX | Nov 26, 2024 | 10.01 | -1.96 |
MarineMax | HZO | Nov 26, 2024 | 32.16 | -3.68 |
Marinus Pharmaceuticals | MRNS | Nov 26, 2024 | 0.32 | -0.62 |
Maris-Tech | MTEK | Nov 26, 2024 | 2.22 | +23.33 |
Markel | MKL | Nov 26, 2024 | 1 775.73 | +0.80 |
Marker Therapeutics | MRKR | Nov 26, 2024 | 3.26 | -2.10 |
Market Vectors Bdc Income ETF | BIZD | Nov 26, 2024 | 16.72 | -0.12 |
Market Vectors Investment Grade | FLTR | Nov 26, 2024 | 25.51 | +0.08 |
Market Vectors Israel ETF | ISRA | Nov 26, 2024 | 43.07 | +0.02 |
Market Vectors Preferred Securi | PFXF | Nov 26, 2024 | 17.99 | -0.55 |
MarketAxess | MKTX | Nov 26, 2024 | 261.02 | -1.05 |
MarketWise A | MKTW | Nov 26, 2024 | 0.51 | -1.74 |
Markforged | MKFG | Nov 26, 2024 | 4.09 | -4.88 |
Marpai A | MRAI | Nov 26, 2024 | 1.94 | 0.00 |
Marqeta A | MQ | Nov 26, 2024 | 3.83 | -4.73 |
Marriott International A | MAR | Nov 26, 2024 | 288.18 | +0.06 |
Marriott Vacations Worldwide | VAC | Nov 26, 2024 | 96.49 | -2.11 |
Mars Acquisition | MARX | Nov 26, 2024 | 11.13 | +0.09 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.